Recruiting studies: Iris Tumor

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Ramucirumab (Cyramza), Nal-IRI (ONIVYDE) and Trifluridine/Tipiracil (Lonsurf) in Second Line Metastatic Gastric Cancer .
Phase 1/Phase 2 · 1 location(s) · National Health Research Institutes, Taiwan · NCT05927857 Physical Activity and Community EmPOWERment Project
NA · 2 location(s) · University of North Carolina, Chapel Hill · NCT06740162 Observational Study of Iris Tumors
Phase N/A · 1 location(s) · Oregon Health and Science University · NCT03809585 Sequential TAS-OX Alternating With TAS-IRI Plus Bevacizumab for Late-Line Metastatic Colorectal Cancer
Phase 2 · 9 location(s) · Rutgers, The State University of New Jersey · NCT05806931 Improved Recovery by Iron Following Surgery With Blood Loss, the IRIS-trial
Phase 3 · 1 location(s) · Jon Unosson · NCT05744219 Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Phase N/A · 2 location(s) · Sanford Health · NCT01793168 Liposomal Irinotecan and Leucovorin/5-fluorouracil Plus Bevacizumab in Metastatic Colorectal Cancer
Phase 2 · 1 location(s) · Hebei Medical University Fourth Hospital · NCT06184698 Neoadjuvant Chemoradiation With Nal-IRI and Capecitabine Guided by UGT1A1 Status in Patients With Rectal Cancer
Phase 2 · 1 location(s) · Hebei Medical University Fourth Hospital · NCT06210971 Nal-IRI/5-FU/LV Chemotherapy Combined With PD-L1 Inhibitor and Multi-target Anti-angiogenic Small Molecule±SBRT as Secon
Phase 2 · 1 location(s) · The Affiliated Nanjing Drum Tower Hospital of Nanjing Univer · NCT06662006 Stage I HER2 Positive Invasive Breast Cancer De-escalation Study(IRIS)
Phase 2 · 1 location(s) · Fudan University · NCT04383275

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.